The report analyzes and forecasts the Disposable diabetes devices market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2019 to 2027. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
Diabetes mellitus (DM) is often referred as diabetes and also described as a group of metabolic diseases which involved with the hormone insulin. In diabetes, the blood glucose or the blood sugar level is very high. Over time, having a high level of sugar or glucose in the blood causes severe health problems. There are three types of diabetes such as type 1 diabetes, type 2 diabetes, and gestational diabetes. The type 1 diabetes usually occurs in children and young adults whether type 2 diabetes is usually developed in any age group. Type 2 diabetes is the most commonly occurred type of diabetes. The gestational diabetes is developed in some women at pregnancy time which is temporary and subsidized after the child birth. There are various disposable devices used for the diagnosis of blood glucose and uptake of insulin to maintain the blood glucose level. The diabetes diagnosis is normally done by a simple blood test Hemoglobin A1c test, random blood sugar test, fasting blood sugar test and oral glucose tolerance test.
The increasing obese population worldwide and rapidly changing dietary habits along with the changing lifestyle leads to the rising prevalence of diabetes as a disease and boost the global diabetes market.
The report comprises a detailed value chain analysis, which provides a comprehensive view of the global Disposable diabetes devices market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view of the Disposable diabetes devices market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The report provides size (in terms of volume and value) of Disposable diabetes devices market for the base year 2018 and the forecast between 2019 and 2027. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This research report categorizes the global Disposable Diabetes Devices market by top players/brands, region, type and end user. This report also studies the global Disposable Diabetes Devices market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Bayer Healthcare
Abbott Laboratories
Johnson& Johnson
Becton Dickinson
F.Hoffmann La-Roche
Novo Nordisk
Medtronic
Sanofi
ARKRAY
Terumo
Market size by Product
Diagnostics Devices
Delivery Devices
Market size by End User
Hospitals Pharmacies
Retail Pharmacies
E-Commerce
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
In this study, the years considered to estimate the market size of Disposable Diabetes Devices are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2027
Reasons to Purchase this Report:
- Estimates 2019-2027 Disposable diabetes devices market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding.
Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.
Key Questions Answered in the Report
The report addresses key questions concerning the market evolution and overarching trends shaping global Disposable diabetes devices market growth. Some of the key questions answered in the report include-
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Diabetes Devices Market, By Product
7.1. Diabetes Devices Market, by Product, 2021-2030
7.1.1. BGM Devices
7.1.1.1. Market Revenue and Forecast (2016-2030)
7.1.2. Insulin Delivery Devices
7.1.2.1. Market Revenue and Forecast (2016-2030)
Chapter 8. Global Diabetes Devices Market, By Distribution Channel
8.1. Diabetes Devices Market, by Distribution Channel, 2021-2030
8.1.1. Hospitals Pharmacies
8.1.1.1. Market Revenue and Forecast (2016-2030)
8.1.2. Retail Pharmacies
8.1.2.1. Market Revenue and Forecast (2016-2030)
8.1.3. Diabetes Clinics/ Centers
8.1.3.1. Market Revenue and Forecast (2016-2030)
8.1.4. Online Pharmacies
8.1.4.1. Market Revenue and Forecast (2016-2030)
Chapter 9. Global Diabetes Devices Market, By End User
9.1. Diabetes Devices Market, by End User, 2021-2030
9.1.1. Hospitals
9.1.1.1. Market Revenue and Forecast (2016-2030)
9.1.2. Homecare
9.1.2.1. Market Revenue and Forecast (2016-2030)
9.1.3. Diagnostic Centers
9.1.3.1. Market Revenue and Forecast (2016-2030)
Chapter 10. Global Diabetes Devices Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Product (2016-2030)
10.1.2. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.1.3. Market Revenue and Forecast, by End User (2016-2030)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Product (2016-2030)
10.1.4.2. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.1.4.3. Market Revenue and Forecast, by End User (2016-2030)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Product (2016-2030)
10.1.5.2. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.1.5.3. Market Revenue and Forecast, by End User (2016-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Product (2016-2030)
10.2.2. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.2.3. Market Revenue and Forecast, by End User (2016-2030)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Product (2016-2030)
10.2.4.2. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.2.4.3. Market Revenue and Forecast, by End User (2016-2030)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Product (2016-2030)
10.2.5.2. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.2.5.3. Market Revenue and Forecast, by End User (2016-2030)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Product (2016-2030)
10.2.6.2. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.2.6.3. Market Revenue and Forecast, by End User (2016-2030)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Product (2016-2030)
10.2.7.2. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.2.7.3. Market Revenue and Forecast, by End User (2016-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Product (2016-2030)
10.3.2. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.3.3. Market Revenue and Forecast, by End User (2016-2030)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Product (2016-2030)
10.3.4.2. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.3.4.3. Market Revenue and Forecast, by End User (2016-2030)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Product (2016-2030)
10.3.5.2. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.3.5.3. Market Revenue and Forecast, by End User (2016-2030)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Product (2016-2030)
10.3.6.2. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.3.6.3. Market Revenue and Forecast, by End User (2016-2030)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Product (2016-2030)
10.3.7.2. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.3.7.3. Market Revenue and Forecast, by End User (2016-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Product (2016-2030)
10.4.2. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.4.3. Market Revenue and Forecast, by End User (2016-2030)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Product (2016-2030)
10.4.4.2. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.4.4.3. Market Revenue and Forecast, by End User (2016-2030)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Product (2016-2030)
10.4.5.2. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.4.5.3. Market Revenue and Forecast, by End User (2016-2030)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Product (2016-2030)
10.4.6.2. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.4.6.3. Market Revenue and Forecast, by End User (2016-2030)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Product (2016-2030)
10.4.7.2. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.4.7.3. Market Revenue and Forecast, by End User (2016-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Product (2016-2030)
10.5.2. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.5.3. Market Revenue and Forecast, by End User (2016-2030)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Product (2016-2030)
10.5.4.2. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.5.4.3. Market Revenue and Forecast, by End User (2016-2030)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Product (2016-2030)
10.5.5.2. Market Revenue and Forecast, by Distribution Channel (2016-2030)
10.5.5.3. Market Revenue and Forecast, by End User (2016-2030)
Chapter 11. Company Profiles
11.1. Medtronic plc
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Abbott Laboratories
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. F.Hoffmann-La-Ltd
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Bayer AG
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Lifescan, Inc.
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. B Braun Melsungen AG
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Lifescan, Inc.
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Dexcom Inc.
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Insulet Corporation
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Ypsomed Holdings
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
11.11. Companion Medical
11.11.1. Company Overview
11.11.2. Product Offerings
11.11.3. Financial Performance
11.11.4. Recent Initiatives
11.12. Sanofi
11.12.1. Company Overview
11.12.2. Product Offerings
11.12.3. Financial Performance
11.12.4. Recent Initiatives
11.13. Valeritas Holding Inc.
11.13.1. Company Overview
11.13.2. Product Offerings
11.13.3. Financial Performance
11.13.4. Recent Initiatives
11.14. Novo Nordisk
11.14.1. Company Overview
11.14.2. Product Offerings
11.14.3. Financial Performance
11.14.4. Recent Initiatives
11.15. Arkray, Inc.
11.15.1. Company Overview
11.15.2. Product Offerings
11.15.3. Financial Performance
11.15.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms